About: A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
Creator	Day, Matthew Hewitt, Kristi Keith, Philip Moyer, Lou Perkins, Linda Wells, Adam
source	Medline; PMC
abstract	covid:ea6f17478c95e999ae5bdd4e0f621ca46b8b2cb0#abstract
has issue date	2020-04-02(xsd:dateTime)
bibo:doi	10.1186/s13054-020-2836-4
bibo:pmid	32241301
has license	cc-by
sha1sum (hex)	ea6f17478c95e999ae5bdd4e0f621ca46b8b2cb0
schema:url	https://doi.org/10.1186/s13054-020-2836-4
resource representing a document's title	A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
has PubMed Central identifier	PMC7117947
has PubMed identifier	32241301
schema:publication	Crit Care
resource representing a document's body	covid:ea6f17478c95e999ae5bdd4e0f621ca46b8b2cb0#body_text
is schema:about of	named entity 'USE OF' named entity 'NOVEL CORONAVIRUS' named entity 'TREATMENT' named entity 'NOVEL' named entity 'THERAPEUTIC PLASMA EXCHANGE' named entity 'APPROACH' named entity 'COVID-19' named entity 'ARGUMENT' named entity 'mechanical ventilator' named entity 'coronavirus' named entity 'infection' named entity 'host response' named entity 'sepsis' named entity 'supportive care' named entity 'endothelial' named entity 'randomized controlled trial' named entity 'antimicrobials' named entity 'COVID-19' named entity 'inflammatory cytokines' named entity '3/3' named entity 'coronavirus' named entity 'sepsis' named entity '1/3' named entity 'multiple organ failure' named entity 'rescue therapy' named entity 'pediatric patients' named entity 'septic shock' named entity 'preprint' named entity 'rescue therapy' named entity 'plasma exchange' named entity 'plasma exchange' named entity 'sepsis' named entity 'MODS' named entity 'randomized trials' named entity 'hemodynamic' named entity 'COVID' named entity 'pneumonia' named entity 'hypercoagulable state' named entity 'pneumonia' named entity 'standard of care' named entity 'source control' named entity 'multiple organ failure' named entity 'sepsis' named entity 'ARDS' named entity 'ARDS' named entity 'meta-analysis' named entity 'subgroup analysis' named entity 'DOI' named entity 'coronavirus' named entity 'doi' named entity 'morbidity' named entity 'H1N1 influenza' named entity 'nitric oxide' named entity 'ECMO' named entity 'ARDS' named entity 'ARDS' named entity 'ARDS' named entity 'fulminant' named entity 'vasopressors' named entity 'fulminant' named entity 'COVID-19' named entity 'plasma exchange' named entity 'COVID-19' named entity 'therapeutic' named entity 'coronavirus' named entity 'plasma exchange' named entity 'argument' named entity 'fulminant'
is part of of	covid:ea6f17478c95e999ae5bdd4e0f621ca46b8b2cb0#abstract A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19 covid:ea6f17478c95e999ae5bdd4e0f621ca46b8b2cb0#body_text

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software